CAPTRUST FINANCIAL ADVISORS - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 163 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$66,000
-71.7%
20,855
-62.6%
0.00%
-100.0%
Q1 2022$233,000
+23200.0%
55,821
+23158.8%
0.00%
Q4 2021$1,000
-50.0%
240
-25.7%
0.00%
Q3 2021$2,0000.0%3230.0%0.00%
Q2 2021$2,0000.0%3230.0%0.00%
Q1 2021$2,000323
+546.0%
0.00%
Q3 2020$0
-100.0%
50
-83.3%
0.00%
Q2 2020$1,0003000.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$144,839,00011.40%
Eversept Partners, LP 4,755,480$32,004,3802.41%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$109,116,0001.27%
EAM Global Investors LLC 365,719$2,461,0000.68%
Signature Wealth Management Partners, LLC 87,666$590,0000.57%
Jackson Creek Investment Advisors LLC 221,043$1,488,0000.52%
Tranquilli Financial Advisor LLC 71,414$481,0000.39%
Hillsdale Investment Management Inc. 611,200$4,113,0000.34%
EAM Investors, LLC 259,873$1,749,0000.26%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$1,211,0000.25%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders